The risk/benefit ratio of depot neuroleptics: a Scandinavian perspective.

No abstract is available for this paper.

• Publication year

  1984

• Venue

  The Journal of Clinical Psychiatry

• Publication date

  1984-05-01

• Fields of study

  Medicine, Psychology

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• A Neurophysiological Rationale for the Use of the Relaxation Response: Neurological Desensitization

  2019cites this paper
• Stability of the diagnosis of seasonal affective disorder in a long-term prospective study.

  2018cites this paper
• Perceptions and knowledge of antipsychotics among mental health professionals and patients

  2017cites this paper
• Use of Solid Dispersions and Inclusion Complexation for Enhancing Oral Bioavailability of Ziprasidone in Treating Schizophrenia

  2017cites this paper
• WITHDRAWN: Drugs versus placebo for dysthymia.

  2015cites this paper
• Major Depressive Disorder

  2015cites this paper
• The role of long-acting injectable antipsychotics in schizophrenia: a critical appraisal

  2014cites this paper
• La dépression atypique : perspectives cliniques Atypical depression: Clinical perspectives M. Lutz ∗ , A. Morali , J.-P. Lang

  2013cites this paper
• Trimipramine, Anxiety, Depression and Sleep

  2012cites this paper
• Long-acting risperidone compared with oral olanzapine and haloperidol depot in schizophrenia: a Belgian cost-effectiveness analysis

  2012cites this paper
• Long-acting injectable antipsychotics and the management of nonadherence

  2011cites this paper
• Comparison of long-acting antipsychotic injection and oral antipsychotics

  2011cites this paper
• The Biopsychosocial Approach to Understanding, Subtyping, and Treating Depression: Results from the National Comorbidity Survey - Replication.

  2011cites this paper
• Long-acting injectable antipsychotics in the treatment of schizophrenia: their role in relapse prevention

  2010cites this paper
• Long-acting typical and atypical antipsychotics in treatment of schizophrenia: A retrospective comparison

  2009cites this paper
• Clinical Pitfalls in the Diagnosis of Ataque de Nervios: A Case Study

  2009cites this paper
• Insomnia: pathophysiology and implications for treatment.

  2007cites this paper
• Treatment of depression with atypical features: a meta-analytic approach.

  2006cites this paper
• Midbrain binding of [123I]nor-β-CIT in atypical depression ☆

  2006cites this paper
• Selecting Patients for Long-acting Novel Antipsychotic Therapy

  2006cites this paper
• Long-acting risperidone vs. placebo in the treatment of hospital inpatients with schizophrenia.

  2005cites this paper
• Remission in schizophrenia: Results from a 1-year study of long-acting risperidone injection.

  2005cites this paper
• Mejorías clínicas significativas con risperidona de larga duración en pacientes con esquizofrenia previamente estables con neurolépticos depote convencionales

  2004cites this paper
• Patients with schizophrenia previously stabilized on conventional depot antipsychotics experience significant clinical improvements following treatment with long-acting risperidone

  2004cites this paper
• Toward a Puerto Rican Popular Nosology: Nervios and Ataque de Nervios

  2003cites this paper
• Psychopharmacology, Placebo and Psychotherapy

  2002cites this paper
• Partial validation of the atypical features subtype of major depressive disorder.

  2002cites this paper
• Corticotropin-releasing hormone in depression and post-traumatic stress disorder.

  2001cites this paper
• Medikamentose Therapie von Personlichkeitsstorungen

  1999cites this paper
• Subtypes of Ataques de Nervios: The Influence of Coexisting Psychiatric Diagnosis

  1998cites this paper
• MAOIs in the Contemporary Treatment of Depression

  1995cites this paper
• Psychopathology in patients with endogenous Cushing's syndrome: ‘atypical’ or melancholic features

  1995cites this paper
• Risk-Benefit Assessment of Newer Versus Older Monoamine Oxidase (MAO) Inhibitors

  1994cites this paper
• Guideline Development and Use

  1993cites this paper
• Low-dose depot medication in schizophrenia.

  1993cites this paper
• Contrasts between symptoms of summer depression and winter depression.

  1991cites this paper
• A current view of the interface between borderline personality disorder and depression.

  1991cites this paper
• Extrapyramidale Nebenwirkungen bei neuroleptischer Therapie

  1990cites this paper
• Wann, wie lange und bei welchen Zustandsbildern ist eine neuroleptische Langzeit-(Depot-)therapie indiziert?

  1990cites this paper
• Neurasthenia in the 1980s: chronic mononucleosis, chronic fatigue syndrome, and anxiety and depressive disorders.

  1990cites this paper
• Dietary treatment of depression

  1990cites this paper
• Antidepressants Not Effective in Headache Associated with Minor Closed Head Injury

  1989cites this paper
• Depotneuroleptika — Ein Fortschritt?

  1987cites this paper
• Progress in pharmacotherapy of borderline disorders. A double-blind study of amitriptyline, haloperidol, and placebo.

  1986cites this paper
• Synergistic action of alprazolam with tranylcypromine in drug-resistant atypical depression with panic attacks.

  1986cites this paper
• Chemotherapy With Neuroleptics

  1985cites this paper